Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hasselaar

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Journal of Cellular Biochemistry|July 1, 1992
SPARC antagonizes the effect of basic fibroblast growth factor on the migration of bovine aortic endothelial cellsP Hasselaar, E H Sage
The Biochemical Journal|September 15, 1986
PAF-acether (1-O-hexadecyl/octadecyl-2-acetyl-sn-glycero-3-phosphocholine)-induced fibrinogen binding to platelets depends on metabolic energyE Kloprogge, P Hasselaar, J W Akkerman
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 1, 1991
Differential expression of extracellular proteins is correlated with angiogenesis in vitroM L Iruela-Arispe, P Hasselaar, H Sage
Biochimica Et Biophysica Acta|August 6, 1986
Stimulus-aggregation coupling in platelets activated with PAF-acetherE Kloprogge, P Hasselaar, G Gorter, et al.
The Journal of Biological Chemistry|July 15, 1991
SPARC induces the expression of type 1 plasminogen activator inhibitor in cultured bovine aortic endothelial cellsP Hasselaar, D J Loskutoff, M Sawdey, et al.
Thrombosis and Haemostasis|February 25, 1988
Thrombosis associated with antiphospholipid antibodies cannot be explained by effects on endothelial and platelet prostanoid synthesisP Hasselaar, R H Derksen, L Blokzijl, et al.
Lancet (London, England)|July 25, 1987
Lack of efficacy of plasma-exchange in removing antiphospholipid antibodiesR H Derksen, P Hasselaar, L Blokzijl, et al.
Thrombosis and Haemostasis|April 12, 1990
Crossreactivity of antibodies directed against cardiolipin, DNA, endothelial cells and blood plateletsP Hasselaar, R H Derksen, L Blokzijl, et al.
Clinical Rheumatology|March 1, 1990
The antiphospholipid antibody dilemmaR H Derksen, P Hasselaar, J D Oosting, et al.
Thrombosis and Haemostasis|September 29, 1989
Synergistic effect of low doses of tumor necrosis factor and sera from patients with systemic lupus erythematosus on the expression of procoagulant activity by cultured endothelial cellsP Hasselaar, R H Derksen, J D Oosting, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of Cellular Biochemistry|July 1, 1992
SPARC antagonizes the effect of basic fibroblast growth factor on the migration of bovine aortic endothelial cellsP Hasselaar, E H Sage
The Biochemical Journal|September 15, 1986
PAF-acether (1-O-hexadecyl/octadecyl-2-acetyl-sn-glycero-3-phosphocholine)-induced fibrinogen binding to platelets depends on metabolic energyE Kloprogge, P Hasselaar, J W Akkerman
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 1, 1991
Differential expression of extracellular proteins is correlated with angiogenesis in vitroM L Iruela-Arispe, P Hasselaar, H Sage
Biochimica Et Biophysica Acta|August 6, 1986
Stimulus-aggregation coupling in platelets activated with PAF-acetherE Kloprogge, P Hasselaar, G Gorter, et al.
The Journal of Biological Chemistry|July 15, 1991
SPARC induces the expression of type 1 plasminogen activator inhibitor in cultured bovine aortic endothelial cellsP Hasselaar, D J Loskutoff, M Sawdey, et al.
Thrombosis and Haemostasis|February 25, 1988
Thrombosis associated with antiphospholipid antibodies cannot be explained by effects on endothelial and platelet prostanoid synthesisP Hasselaar, R H Derksen, L Blokzijl, et al.
Lancet (London, England)|July 25, 1987
Lack of efficacy of plasma-exchange in removing antiphospholipid antibodiesR H Derksen, P Hasselaar, L Blokzijl, et al.
Thrombosis and Haemostasis|April 12, 1990
Crossreactivity of antibodies directed against cardiolipin, DNA, endothelial cells and blood plateletsP Hasselaar, R H Derksen, L Blokzijl, et al.
Clinical Rheumatology|March 1, 1990
The antiphospholipid antibody dilemmaR H Derksen, P Hasselaar, J D Oosting, et al.
Thrombosis and Haemostasis|September 29, 1989
Synergistic effect of low doses of tumor necrosis factor and sera from patients with systemic lupus erythematosus on the expression of procoagulant activity by cultured endothelial cellsP Hasselaar, R H Derksen, J D Oosting, et al.
Pageof 2